Kallikrein 11 Protein (KLK11) (His tag)
Aperçu rapide pour Kallikrein 11 Protein (KLK11) (His tag) (ABIN7319354)
Antigène
Voir toutes Kallikrein 11 (KLK11) ProtéinesType de proteíne
Origine
Source
Pureté
-
-
Purification/Conjugué
- Cette Kallikrein 11 protéine est marqué à la His tag.
-
Fonction
- Recombinant Human Kallikrein 11/KLK11 Protein (His Tag)
-
Séquence
- Glu19-Asn250
-
Attributs du produit
- Recombinant Human Kallikrein 11 is produced by our Mammalian expression system and the target gene encoding Glu19-Asn250 is expressed with a 6His tag at the C-terminus.
-
niveau d'endotoxine
- < 1.0 EU per μg as determined by the LAL method.
-
-
Vous souhaitez d'autres options pour ce Protein ?
!Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Frozen, Liquid
-
Buffer
- Supplied as a 0.2 μm filtered solution of 20 mM TrisHCl, 150 mM NaCl, 2 mM CaCl2, pH 8.0.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
-
-
- Kallikrein 11 (KLK11)
-
Autre désignation
- Kallikrein 11/KLK11
-
Sujet
-
Background: Human Kallikrein 11 (KLK11) is a member of tissue kallikrein family which are extracellular serine proteases consisting of 15 members. Two isoforms of KLK11 are differentially expressed. Isoform 1 is predominantly expressed in brain and isoform 2 is preferentially expressed in prostate. Isoform 1 consists of a signal peptide,a short pro peptide and the mature chain.Isoform 2 contains an extra 32 amino acid N terminal to full-length isoform 1.KLK11 is a novel marker for ovarian and prostate cancer carcinomas. KLK11 can be activated by thermolysin and is active against a thioester substrate.
Synonym: Kallikrein-11, hK11, Hippostasin, Serine Protease 20, Trypsin-Like Protease, KLK11, PRSS20, TLSP
-
Poids moléculaire
- 26.3 kDa
-
NCBI Accession
- NP_006844
-
Pathways
- Système du Complément
Antigène
-